v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net sales $ 5,789.2 $ 7,524.7 $ 6,737.4
Cost of sales 3,640.9 4,930.7 4,297.8
Gross profit 2,148.3 2,594.0 2,439.6
Operating expenses:      
Selling, general and administrative 873.3 1,040.9 1,082.9
Research and development 459.7 543.6 565.0
Amortization of purchased intangible assets 327.1 440.0 510.0
Restructuring costs, net 29.7 63.0 85.1
Asset impairments 571.4 1,119.6 0.0
Total operating expenses 2,261.2 3,207.1 2,243.0
Operating income (loss) (112.9) (613.1) 196.6
Other income (expense), net 59.7 (0.5) (26.5)
Interest expense (675.8) (588.9) (561.2)
Interest income 11.1 2.8 1.9
Loss from continuing operations before income taxes (717.9) (1,199.7) (389.2)
Income tax (expense) benefit (133.4) 15.0 39.2
Loss from continuing operations (851.3) (1,184.7) (350.0)
Loss from discontinued operations, net of income tax (expense) benefit of $184.0, $(1.9) and $32.6, respectively (599.6) (102.2) (112.6)
Net loss (1,450.9) (1,286.9) (462.6)
Series A convertible preferred stock dividends (61.8) (59.0) (57.3)
Net loss attributable to common stockholders $ (1,512.7) $ (1,345.9) $ (519.9)
Basic:      
Loss from continuing operations per share $ (4.33) $ (6) $ (2)
Loss from discontinued operations per share (2.84) (0.49) (0.55)
Loss per share (7.17) (6.49) (2.55)
Diluted:      
Loss from continuing operations per share (4.33) (6) (2)
Loss from discontinued operations per share (2.84) (0.49) (0.55)
Loss per share $ (7.17) $ (6.49) $ (2.55)
Weighted average shares outstanding:      
Basic 210.9 207.4 203.6
Diluted 210.9 207.4 203.6